敗血症診療トレーニング

出版社: 金芳堂
著者:
発行日: 2024-02-05
分野: 臨床医学:一般  >  救命/救急
ISBN: 9784765319782
電子書籍版: 2024-02-05 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

3,960 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,960 円(税込)

商品紹介

本書は救急医、初期研修医、内科・外科後期研修医向けに、敗血症診療についてまとめた一冊となっています。
ほとんどが日常的に遭遇するケースなので、解説部分から読んでも、知識を深めることができ、現場で、適切な対応が行えるようになります。

目次

  • 第1章 敗血症診療のポイント
    敗血症とは
    敗血症の疫学と予後
    敗血症診療の流れ
    敗血症診療ガイドライン

    第2章 救急外来における敗血症診療
    症例1
    敗血症の初期診療・診断【敗血症の疑い方】
    難易度:★★☆☆☆

    症例2
    敗血症の初期診療・診断【敗血症の確定診断】
    難易度:★★★☆☆

    症例3
    敗血症の初期診療・診断【敗血症の初期輸液】
    難易度:★☆☆☆☆

    症例4
    敗血症の初期診療・診断【敗血症初期診療の循環作動薬】
    難易度:★★☆☆☆

    症例5
    敗血症の初期診療・診断【敗血症初期蘇生の評価方法】
    難易度:★★★★☆

    症例6
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与】
    難易度:★★★★☆

    症例7
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★☆☆☆

    症例8
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★★☆☆

    症例9
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★★★★

    症例10
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★★★☆

    症例11
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★★★☆

    症例12
    敗血症の初期診療・診断【敗血症初期診療の抗菌薬投与:各論】
    難易度:★★★★☆

    症例13
    敗血症の初期診療・診断【気管挿管】
    難易度:★★★☆☆

    第3章 ICU/ICU退出後における敗血症診療
    症例14
    敗血症の集中治療【人工呼吸器管理】
    難易度:★★★★☆

    症例15
    敗血症の集中治療【敗血症の水分管理】
    難易度:★★★★☆

    症例16
    敗血症の集中治療管理【循環作動薬】
    難易度:★★★☆☆

    症例17
    敗血症の集中治療管理【抗菌薬の投与時間の延長、デ・エスカレーション】
    難易度:★★★☆☆

    症例18
    敗血症の集中治療管理【抗ウイルス薬・抗真菌薬】
    難易度:★★☆☆☆

    症例19
    敗血症の集中治療管理【鎮痛・鎮静薬】
    難易度:★☆☆☆☆

    症例20
    敗血症の集中治療管理【DIC治療】
    難易度:★★★★☆

    症例21
    敗血症の集中治療管理【輸血】
    難易度:★★☆☆☆

    症例22
    敗血症の集中治療管理【血液浄化法】
    難易度:★★★☆☆

    症例23
    敗血症の集中治療管理【抗潰瘍薬】
    難易度:★☆☆☆☆

    症例24
    敗血症の集中治療管理【経腸栄養】
    難易度:★★☆☆☆

    症例25
    敗血症の集中治療管理【ステロイド投与】
    難易度:★★☆☆☆

    症例26
    敗血症の集中治療管理【血糖・体温管理】
    難易度:★★★☆☆

    症例27
    敗血症の集中治療管理【早期リハビリテーション】
    難易度:★★☆☆☆

    症例28
    敗血症の集中治療後に関して【回復過程と社会復帰】
    難易度:★★★★★

    おわりに
    プロフィール

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 敗血症診療のポイント

P.7 掲載の参考文献
1) Vincent JL, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 ; 22 : 707-710.
2) Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 ; 101 : 1644-1655.
3) Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 ; 315 : 801-810.
4) Abe T, et al. Epidemiology of sepsis and septic shock in intensive care units between sepsis-2 and sepsis-3 populations : sepsis prognostication in intensive care unit and emergency room (SPICE-ICU). J Intensive Care. 2020 ; 8 : 44.
5) Rhee C, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017 ; 318 : 1241-1249.
6) Oduncu AF, et al. Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department. Am J Emerg Med. 2021 ; 48 : 54-59.
7) Davidson JE, et al. Family response to critical illness : post-intensive care syndrome-family. Crit Care Med. 2012 ; 40 : 618-624.
8) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
9) Evans L, et al. Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 ; 47 : 1181-1247.

第2章 救急外来における敗血症診療

P.14 掲載の参考文献
1) Seymour CW, et al. Assessment of Clinical Criteria for Sepsis : For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 ; 315 : 762-774.
2) Shiraishi A, et al. Quick sequential organ failure assessment versus systemic inflammatory response syndrome criteria for emergency department patients with suspected infection. Sci Rep. 2021 ; 11 : 5347.
3) Jouffroy R, et al. Impact of Prehospital Antibiotic Therapy on Septic Shock Mortality. Prehosp Emerg Care. 2021 ; 25 : 317-324.
4) Abe T, et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan : the FORECAST study. Crit Care. 2018 ; 22 : 322.
5) Canet E, et al. qSOFA as predictor of mortality and prolonged ICU admission in Emergency Department patients with suspected infection. J Crit Care. 2018 ; 48 : 118-123.
P.22 掲載の参考文献
1) Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 ; 315 : 801-810.
2) Raith EP, et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA. 2017 ; 317 : 290-300.
3) Vincent JL, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 ; 22 : 707-710.
4) Lockrem JD, et al. Severity of illness : APACHE II analysis of an ICU population. Cleve Clin J Med. 1991 ; 58 : 477-486.
P.28 掲載の参考文献
1) Perner A, et al. 6S Trial Group ; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012 ; 367 : 124-134.
2) Finfer S, et al. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004 ; 350 : 2247-2256.
3) Evans L, et al. Executive Summary : Surviving Sepsis Campaign : International Guidelines for the Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021 ; 49 : 1974-1982.
4) Semler MW, et al. SMART Investigators and the Pragmatic Critical Care Research Group. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018 ; 378 : 829-839.
5) Self WH, et al. SALT-ED Investigators. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med. 2018 ; 378 : 819-828.
P.33 掲載の参考文献
1) De Backer D, et al. Dopamine versus norepinephrine in the treatment of septic shock : a meta-analysis. Crit Care Med. 2012 ; 40 : 725-730.
2) Evans L, et al. Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 ; 47 : 1181-1247.
3) Loubani OM, et al. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care. 2015 ; 30 : 653.e9-17.
P.38 掲載の参考文献
1) Zhou X, et al. Use of stepwise lactate kinetics-oriented hemodynamic therapy could improve the clinical outcomes of patients with sepsis-associated hyperlactatemia. Crit Care. 2017 ; 21 : 33.
2) Puskarich MA, et al. Emergency Medicine Shock Research Network (EMSHOCKNET). Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012 ; 19 : 252-258.
3) Greenwood JC, et al. End Points of Sepsis Resuscitation. Emerg Med Clin North Am. 2017 ; 35 : 93-107.
P.44 掲載の参考文献
1) Rivers E, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 ; 345 : 1368-1377.
2) Pruinelli L, et al. Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock. Crit Care Med. 2018 ; 46 : 500-505.
3) Levy MM, et al. The Surviving Sepsis Campaign Bundle : 2018 Update. Crit Care Med. 2018 ; 46 : 997-1000.
4) Liu VX, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017 ; 196 : 856-863.
P.50 掲載の参考文献
1) Higuchi T, et al. Severity classification and prognosis in hospitalized elderly patients with community-acquired pneumonia. Nihon Ronen Igakkai Zasshi. 2007 ; 44 : 483-489.
P.56 掲載の参考文献
1) Jorgensen KJ, et al. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev. 2014 ; 2014 : CD004707.
2) Clinical Infectious Diseases -血管内カテーテル関連感染症の診断と治療に関する実践的臨床ガイドライン : 米国感染症学会による2009年改訂版. https://dcc.ncgm.go.jp/information/pdf/IDSA_CRBS_Guidelines2009.pdf (2023年7月アクセス済)
P.62 掲載の参考文献
1) Tanizaki R, et al. Clinical impact of perinephric fat stranding detected on computed tomography in patients with acute pyelonephritis : a retrospective observational study. Eur J Clin Microbiol Infect Dis. 2019 ; 38 : 2185-2192.
2) Karakonstantis S, et al. The clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteremia. A review and meta-analysis. Infect Dis (Lond). 2018 ; 50 : 648-659.
3) Lafon T, et al. Community-acquired Staphylococcus aureus bacteriuria : a warning microbiological marker for infective endocarditis? BMC Infect Dis. 2019 ; 19 : 504.
P.68 掲載の参考文献
1) Wong CH, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score : a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004 ; 32 : 1535-1541.
2) Morgan MS. Diagnosis and management of necrotising fasciitis : a multiparametric approach. J Hosp Infect. 2010 ; 75 : 249-257.
3) Chao CM, et al. Comparison of skin and soft tissue infections caused by Vibrio and Aeromonas species. Surg Infect (Larchmt). 2014 ; 15 : 576-580.
4) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
5) 戸塚恭一. 化学療法の基礎. 抗菌薬の特性と投与方法. 日内科誌 1990 ; 79 : 1627-1631.
P.77 掲載の参考文献
1) Thomas KE, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis. 2002 ; 35 : 46-52.
2) Attia J, et al. The rational clinical examination. Does this adult patient have acute meningitis? JAMA. 1999 ; 282 : 175-181.
3) 浅野裕一朗, ほか. 検査項目と異常値からみた-緊急・重要疾患レッドページ 2章 脳神経・筋疾患 髄膜炎. 臨床検査 2019 ; 63 : 390-391.
4) Lyons TW, et al. Interpretation of Cerebrospinal Fluid White Blood Cell Counts in Young Infants With a Traumatic Lumbar Puncture. Ann Emerg Med. 2017 ; 69 : 622-631.
5) Garcia-De la Rosa G, et al. Interpretation of white blood cell counts in the cerebrospinal fluid of neonates with traumatic lumbar puncture : a retrospective cohort study. BMC Pediatr. 2022 ; 22 : 488.
6) Steele RW, et al. Leukocyte survival in cerebrospinal fluid. J Clin Microbiol. 1986 ; 23 : 965-966.
7) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
8) Up to Date(R). <https://www.uptodate.com/contents/search> Sexton DJ. Dexamethasone to prevent neurologic complications of bacterial meningitis in adults (2023年7月4日アクセス済)
P.82 掲載の参考文献
1) 急性胆管炎・胆嚢炎診療ガイドライン改訂出版委員会. -TG18新基準掲載-急性胆管炎・胆嚢炎診療ガイドライン 2018, 第3版. 医学図書出版, 2018.
2) Kiriyama S, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis : an international multicenter observational study. J Hepatobiliary Pancreat Sci. 2017 ; 24 : 329-337.
3) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
P.88 掲載の参考文献
1) Stollings JL, et al. Rapid-sequence intubation : a review of the process and considerations when choosing medications. Ann Pharmacother. 2014 ; 48 : 62-76.
2) 井桁龍平, ほか. 迅速導入気管挿管 (RSI) -プラクティスは7つのP's. INTENSIVIST. 2019 ; 11 : 669-682.
3) Orser BA. Recommendations for Endotracheal Intubation of COVID-19 Patients. Anesth Analg. 2020 ; 130 : 1109-1110.
4) Saoraya J, et al. Difficult airway predictors were associated with decreased use of neuromuscular blocking agents in emergency airway management : a retrospective cohort study in Thailand. BMC Emerg Med. 2021 ; 21 : 37.

第3章 ICU / ICU退出後における敗血症診療

P.95 掲載の参考文献
1) Ranieri VM. et al. ARDS Definition Task Force. Acute respiratory distress syndrome : the Berlin Definition. JAMA. 2012 ; 307 : 2526-2533.
2) ARDS診療ガイドライン作成委員会. ARDS診療ガイドライン 2021. 日集中医誌 2022 ; 29 : 295-332.
3) Thille AW, et al. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med. 2013 ; 187 : 761-767.
P.102 掲載の参考文献
1) Kuipers S, et al. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis : a systematic review. Crit Care. 2014 ; 18 : 688.
2) Walkey AJ, et al. Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2023 ; 16 : e009494.
P.107 掲載の参考文献
1) De Backer D, et al. SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010 ; 362 : 779-789.
2) Vallabhajosyula S, et al. Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock. Anaesth Intensive Care. 2018 ; 46 : 13-24.
3) Hammond DA, et al. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. J Intensive Care Med. 2019 ; 34 : 805-810.
4) Wu Z, et al. Norepinephrine vs Vasopressin : Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis. Shock. 2020 ; 53 : 50-57.
P.114 掲載の参考文献
1) Clinical and Laboratory Standards Institute(R) : Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. CLSI supplement M100-S29. CLSI, Wayne, PA, 2019.
2) 口広智一. 細菌の自然耐性. 検査と技術 2020 ; 48 : 76-79.
3) Matsumura Y, et al. Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia. Antimicrob Agents Chemother. 2015 ; 59 : 5107-5113.
P.120 掲載の参考文献
1) Papazian L, et al. Cytomegalovirus reactivation in ICU patients. Intensive Care Med. 2016 ; 42 : 28-37.
2) Liss B, et al. 1,3-β-D-Glucan contamination of common antimicrobials. J Antimicrob Chemother. 2016 ; 71 : 913-915.
3) Son HJ, et al. Risk factors and outcomes of patients with ocular involvement of candidemia. PLoS One. 2019 ; 14 : e0222356.
4) Ueda T, et al. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia. PLoS One. 2019 ; 14 : e0216956.
5) 米谷正太. 尿培養と臨床推論. 臨床検査 2023 ; 67 : 618-623.
P.127 掲載の参考文献
1) 岩田聡. 呼吸を助けるくすり 人工呼吸療法中の鎮静・せん妄対策の薬物療法. 薬局 2022 ; 73 : 2208-2212.
2) Devlin JW, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018 ; 46 : e825-e873.
3) 大野博司. 鎮痛薬・筋弛緩薬の使いかた : レジデントのためのクリティカルケア入門セミナー. 医学界新聞. 2010. https://www.igaku-shoin.co.jp/paper/archive/y2010/PA02882_11 (2023年5月2日アクセス済)
4) Sessler CN, et al. The Richmond Agitation-Sedation Scale : validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002 ; 166 : 1338-1344.
5) Schroeppel TJ, et al. Propofol infusion syndrome : a lethal condition in critically injured patients eliminated by a simple screening protocol. Injury. 2014 ; 45 : 245-249.
P.133 掲載の参考文献
1) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992 ; 20 : 864-874.
2) 丸藤哲, ほか. 急性期DIC 診断基準多施設共同前向き試験結果報告. 日救急医会誌 2005 ; 16 : 188-202.
3) 丸藤哲, ほか. 第三次多施設共同前向き試験結果報告 急性期DIC診断基準で診断された敗血症性DICに対するアンチトロンビンの効果. 日救急医会誌 2013 : 24 : 105-115.
P.137 掲載の参考文献
1) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
P.144 掲載の参考文献
1) Forni LG, et al. Extracorporeal renal replacement therapies in the treatment of sepsis : where are we? Semin Nephrol. 2015 ; 35 : 55-63.
2) Thomas ME, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015 ; 87 : 62-73.
3) Stevens PE, et al. Kidney Disease : Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease : synopsis of the kidney disease : improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 ; 158 : 825-830.
4) AKI (急性腎障害) 診療ガイドライン作成委員会. AKI (急性腎障害) 診療ガイドライン 2016. 日腎会誌 2017 ; 59 : 419-533.
P.150 掲載の参考文献
1) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021 ; 8 : e659.
2) Ye Z, et al. Gastrointestinal bleeding prophylaxis for critically ill patients : a clinical practice guideline. BMJ. 2020 ; 368 : l6722.
P.155 掲載の参考文献
1) van Niekerk G, et al. Nutritional support in sepsis : when less may be more. Crit Care. 2020 ; 24 : 53.
2) 堤理恵. 経腸栄養剤の種類とアウトカム. INTENSIVIST. 2019 ; 11 : 364-369.
P.160 掲載の参考文献
1) Annane D, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018 ; 378 : 809-818.
2) Annane D, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I) : Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017 ; 43 : 1751-1763.
P.165 掲載の参考文献
1) van den Berghe G, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 ; 345 : 1359-1367.
2) 山本剛史, ほか. 薬剤性高血糖. 昭和学士会誌 2015 ; 75 : 426-431.
3) Inghammar M, et al. Prognostic significance of body temperature in the emergency department vs the ICU in Patients with severe sepsis or septic shock : A nationwide cohort study. PLoS One. 2020 ; 15 : e0243990.
P.170 掲載の参考文献
1) Cameron S, et al. Early mobilization in the critical care unit : A review of adult and pediatric literature. J Crit Care. 2015 ; 30 : 664-672.
2) 日本集中治療医学会. 重症患者リハビリテーション診療ガイドライン 2023. <https://www.jsicm.org/pdf/230119JSICM_jkortsgJ-ReCIP2023.pdf> (2023年9月1日アクセス済)
3) 西田修, ほか監. 症例から学ぶPICSの予防と早期介入. 日本医事新報社. 2022.
P.175 掲載の参考文献
1) Hayhurst CJ, et al. Intensive Care Unit Delirium : A Review of Diagnosis, Prevention, and Treatment. Anesthesiology. 2016 ; 125 : 1229-1241.
2) 日本集中治療医学会. PICS集中治療後症候群. <https://www.jsicm.org/provider/pics/pics01.html> (2023年9月1日アクセス済)
3) Anderson WG, et al. Passive decision-making preference is associated with anxiety and depression in relatives of patients in the intensive care unit. J Crit Care. 2009 ; 24 : 249-254.
4) Pandolfi F, et al. One-year hospital readmission for recurrent sepsis : associated risk factors and impact on 1-year mortality-a French nationwide study. Crit Care. 2022 ; 26 : 371.
5) Prescott HC, et al. Enhancing Recovery From Sepsis : A Review. JAMA. 2018 ; 319 : 62-75.
6) Sayde GE, et al. Implementing an intensive care unit (ICU) diary program at a large academic medical center : Results from a randomized control trial evaluating psychological morbidity associated with critical illness. Gen Hosp Psychiatry. 2020 ; 66 : 96-102.

最近チェックした商品履歴

Loading...